These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33466461)

  • 1.
    Zhi Y; Ji HJ; Guo H; Lim JH; Byun EB; Kim WS; Seo HS
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33466461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of Cellular and Humoral Immunity against Foot-and-Mouth Disease Virus by Immunization with Virus-Like Particles Encapsulated in Monophosphoryl Lipid A and Liposomes.
    Kim WS; Zhi Y; Guo H; Byun EB; Lim JH; Seo HS
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33142799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the VP1 protein of FMDV integrated chromosomally with mutant Listeria monocytogenes strain induced both humoral and cellular immune responses.
    Mahdy SE; Liu S; Su L; Zhang X; Chen H; Pei X; Wang C
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1919-1929. PubMed ID: 30627793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a recombinant vaccine against foot and mouth disease utilizing mutant attenuated Listeria ivanovii strain as a live vector.
    Mahdy SE; Sijing L; Lin S; Xiang Z; Hao-Tai C; Xiaofang P; Chuan W
    J Virol Methods; 2019 Nov; 273():113722. PubMed ID: 31422118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.
    Jin H; Xiao W; Xiao C; Yu Y; Kang Y; Du X; Wei X; Wang B
    Viral Immunol; 2007 Sep; 20(3):429-40. PubMed ID: 17931113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.
    Du Y; Jiang P; Li Y; He H; Jiang W; Wang X; Hong W
    Vaccine; 2007 Nov; 25(49):8209-19. PubMed ID: 17980939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The High Immunity Induced by the Virus-Like Particles of Foot-and-Mouth Disease Virus Serotype O.
    Xiao Y; Zhang S; Yan H; Geng X; Wang Y; Xu X; Wang M; Zhang H; Huang B; Pang W; Yang M; Tian K
    Front Vet Sci; 2021; 8():633706. PubMed ID: 33718472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
    Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
    Fernandez-Sainz I; Gavitt TD; Koster M; Ramirez-Medina E; Rodriguez YY; Wu P; Silbart LK; de Los Santos T; Szczepanek SM
    Vaccine; 2019 Jun; 37(26):3435-3442. PubMed ID: 31085001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Adenovirus Vector Expressing FMDV RNA Polymerase Combined with a Chimeric VLP Harboring a Neutralizing Epitope as a Prime Boost Strategy to Induce FMDV-Specific Humoral and Cellular Responses.
    Rangel G; Martín V; Bárcena J; Blanco E; Alejo A
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
    Fan H; Tong T; Chen H; Guo A
    Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enhancement of mouse immune response by recombinant adenovirus co-expressing VP1-2A of foot-and-mouth disease virus and porcine IFN-α].
    Su C; Duan X; Cao R; Zheng J; Chen P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1129-32. PubMed ID: 25374073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.